Shares of Puma Biotechnology Inc. PBYI, +4.38% rallied in the prolonged session Thursday after the biotech business talked about it submitted promising follow-up statistics in its meals and Drug Administration advertising utility for a breast cancer medication. Puma shares jumped 17% to $forty.50 after hours. In an early analysis of five years of results, the enterprise noted its breast cancer medication neratinib decreased recurrence of the ailment or demise by way of 26% in sufferers given the remedy versus those given a placebo.
0 komentar:
Posting Komentar